| 摘要 |
<p>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</p> |
| 申请人 |
AMIRA PHARMACEUTICALS, INC. |
发明人 |
HUTCHINSON, JOHN, HOWARD;PRASIT, PETPIBOON, PEPPI;STEARNS, BRIAN, ANDREW;EVANS, JILLIAN, F.;MORAN, MARK;LI, YIWEI;WANG, BOWEI;TRUONG, YEN, PHAM;ROPPE, JEFFREY, ROGER;SCOTT, JILL, MELISSA;ZUNIC, JASMINE, ELEANOR;ARRUDA, JEANNIE, M.;SEIDERS, THOMAS, JON;STOCK, NICHOLAS, SIMON;HADDACH, MUSTAPHA |
